Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 10/20 | 0.62 |
| ▸ | MME | P08473 | 9/20 | 0.62 |
| ▸ | CPA1 | P15085 | 3/20 | 0.62 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.60 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27935801 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL27704335 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL27704333 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL4273366 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL6445682 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL29822661 | 0.97 | MME (0.60) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL30577827 | 0.95 | ACE (0.57) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL29351001 | 0.94 | ACE (0.61) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL31753582 | 0.94 | ACE (0.56) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL32679640 | 0.92 | FOLH1 (0.67) | ACEMMECPA1ACE2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119224161-A | Method for detecting various dipeptides in rumen fluid of ruminant | 中国科学院亚热带农业生态研究所 | 2024-12-31 | — | — | CN | claimed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | claimed |
| WO-2023069598-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-27 | — | — | WO | claimed |
| CN-108645930-A | A kind of his Wei of high performance liquid chromatography chiral mobile phases separation hydrochloric acid Dacca and its five kinds of optical isomers | 覃叶枫 | 2018-10-12 | — | — | CN | claimed |
| CN-106459151-A | Cyclic dipeptide-containing composition | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106455664-A | Composition with high content of cyclic dipeptide | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-105407907-A | Uric acid level lowering agent | SUNTORY HOLDINGS LTD | 2016-03-16 | — | — | CN | claimed |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ASTRAZENECA AB (SE) | 2026-02-05 | — | — | US | disclosed |
| CN-119224161-A | Method for detecting various dipeptides in rumen fluid of ruminant | 中国科学院亚热带农业生态研究所 | 2024-12-31 | — | — | CN | disclosed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | disclosed |
| WO-2023069598-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2020071258-A1 | PROTEIN GLYCATION SUPPRESSANT | 味の素株式会社 | 2020-04-09 | — | — | WO | disclosed |
| CN-109836455-A | Thymopeptide-5 liquid-phase synthesis process based on phosphorus or phosphorous acyloxy benzhydrol and its derivative and auxiliary | 西北工业大学 | 2019-06-04 | — | — | CN | disclosed |
| JP-2002284668-A | PREVENTIVE AND THERAPEUTIC AGENT AGAINST DARKENING | COSMO PRODUCTS KK | 2002-10-03 | — | — | JP | disclosed |
| US-4713445-A | HYPOTENSIVE AGENTS; NONHYDROLYZING; MEDICAL DIAGNOSIS | AKTIEBOLAGET HASSLE (SE) | 1987-12-15 | — | — | US | disclosed |
| US-4609643-A | OLIGOPEPTIDE ANALOG, HYPOTENSIVE | AKTIEBOLAGET HASSLE (SE) | 1986-09-02 | — | — | US | disclosed |
| EP-0045665-B1 | ENZYME INHIBITORS | Aktiebolaget Hässle (SE) | 1985-09-04 | — | — | EP | disclosed |
| US-4424207-A | Enzyme inhibitors | FERRING PHARMACEUTICALS LIMITED (GB) | 1984-01-03 | — | — | US | disclosed |
| EP-0045665-A1 | Enzyme inhibitors | Aktiebolaget Hässle (SE) | 1982-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ATP5ME, ATP5MF, ATP5MK | ACE 1434/4885MME 298/4885CPA1 283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.